Clinical Significance of Combined Detection of CA27-29 and CA153 in Patients with Breast Infiltrating Ductal Carcinoma
LU Chuan-cu
Abstract
LU Chuan-cu
Abstract
Objective To investigate the value of combined detection of CA27-29 and CA15-3 in early diagnosis of breast infiltrating ductal carcinoma. Methods The study included 41 patients with breast infiltrating ductal carcinoma and 33 patients with benign breast disease. 35 healthy volunteers were served as control group. The serum levels of CA27-29 and CA15-3 in all cases were examined by IRMA and CMIA respectively. Results The serum levels of CA27-29 and CA15-3 in patients with breast infiltrating ductal carcinoma were significantly higher than those in patients with benign breast disease and control group( P 0. 05). The positive rates of CA27-29 and CA15-3 in patients with breast infiltrating ductal carcinoma were 65. 9% and 56. 1%,respectively,while the positive rate of combined detection of CA27-29 and CA153 was 80. 5%. It indicated that the abnormal expression of CA27-29 was closely related to the occurrence of breast infiltrating ductal carcinoma. Conclusion The CA27-29 could be served as one of tumor markers in breast infiltrating ductal carcinoma. Combined detection of CA27-29 and CA15-3 might be conducive to early diagnosis of breast infiltrating ductal carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the value of combined detection of CA27-29 and CA15-3 in early diagnosis of breast infiltrating ductal carcinoma. Methods The study included 41 patients with breast infiltrating ductal carcinoma and 33 patients with benign breast disease. 35 healthy volunteers were served as control group. The serum levels of CA27-29 and CA15-3 in all cases were examined by IRMA and CMIA respectively. Results The serum levels of CA27-29 and CA15-3 in patients with breast infiltrating ductal carcinoma were significantly higher than those in patients with benign breast disease and control group( P 0. 05). The positive rates of CA27-29 and CA15-3 in patients with breast infiltrating ductal carcinoma were 65. 9% and 56. 1%,respectively,while the positive rate of combined detection of CA27-29 and CA153 was 80. 5%. It indicated that the abnormal expression of CA27-29 was closely related to the occurrence of breast infiltrating ductal carcinoma. Conclusion The CA27-29 could be served as one of tumor markers in breast infiltrating ductal carcinoma. Combined detection of CA27-29 and CA15-3 might be conducive to early diagnosis of breast infiltrating ductal carcinoma.
Key concepts: Medicine, Ductal carcinoma, Invasive ductal carcinoma, Breast carcinoma, Breast cancer, Carcinoma, Oncology, Internal medicine